154 related articles for article (PubMed ID: 1953990)
1. No alterations in the 5-HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants.
Odagaki Y; Koyama T; Yamashita I
J Neural Transm Gen Sect; 1991; 86(2):85-96. PubMed ID: 1953990
[TBL] [Abstract][Full Text] [Related]
2. Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus.
Newman ME; Ben-Zeev A; Lerer B
Eur J Pharmacol; 1991 Jul; 207(3):209-13. PubMed ID: 1654266
[TBL] [Abstract][Full Text] [Related]
3. [Effects of lithium and antidepressants on monoaminergic receptors and receptor-coupled adenylate cyclase system in rat brain].
Odagaki Y
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):247-58. PubMed ID: 1317819
[TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin attenuates 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat hippocampal membranes.
Okada F; Tokumitsu Y; Nomura Y
J Neurochem; 1989 May; 52(5):1566-9. PubMed ID: 2523468
[TBL] [Abstract][Full Text] [Related]
5. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
6. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.
Rabin RA; Winter JC
Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
8. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
9. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term treatment with lithium and antidepressants on [3H]forskolin binding to rat cerebral cortical membranes.
Odagaki Y; Koyama T; Yamashita I
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):709-16. PubMed ID: 1956996
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
12. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
Devivo M; Maayani S
Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
[TBL] [Abstract][Full Text] [Related]
14. Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase.
Sleight AJ; Marsden CA; Palfreyman MG; Mir AK; Lovenberg W
Eur J Pharmacol; 1988 Sep; 154(3):255-61. PubMed ID: 3234480
[TBL] [Abstract][Full Text] [Related]
15. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
Oksenberg D; Peroutka SJ
Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
[TBL] [Abstract][Full Text] [Related]
17. Characterization of galanin and 5-HT1A receptor coupling to adenylyl cyclase in discrete regions of the rat brain.
Billecocq A; Hedlund PB; Bolaños-Jiménez F; Fillion G
Eur J Pharmacol; 1994 Oct; 269(2):209-17. PubMed ID: 7531647
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
Mørk A; Geisler A
Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine1A receptors are linked to a Gi-adenylate cyclase complex in rat hippocampus.
Harrington MA; Oksenberg D; Peroutka SJ
Eur J Pharmacol; 1988 Sep; 154(1):95-8. PubMed ID: 2972552
[TBL] [Abstract][Full Text] [Related]
20. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
De Vivo M; Maayani S
Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
